Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|September 19, 2022
Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature reviewAndrei Kachmazov, Larisa Bolotina, Anna Kornietskaya, et al.American Journal of Translational Research|October 19, 2023
Precision oncology strategy in cetuximab-resistant ERRFI1-mutant colon cancer: case report of disease progression on afatinibOlesya Kuznetsova, Alexandra Lebedeva, Alexandra Kavun, et al.Frontiers in Oncology|November 29, 2023
Case Report: Progressive disease of BRCA2-mutant colon adenocarcinoma following talazoparib therapyElizaveta Polyanskaya, Alexandra Lebedeva, Olesya Kuznetsova, et al.Cancers|May 16, 2023
Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor TherapyAlexandra Kavun, Egor Veselovsky, Alexandra Lebedeva, et al.International Journal of Molecular Sciences|December 11, 2025
Profiling of CD63 and EpCAM Membrane Proteins of Extracellular Vesicles on Tannic Acid-Coated Magnetic Beads Using Conventional Flow CytometryEkaterina Moiseeva, Igor Sergeev, Vasiliy Chernyshev, et al.World Journal of Gastrointestinal Oncology|April 5, 2024
Prognostic and predictive role of immune microenvironment in colorectal cancerOlesya Kuznetsova, Mikhail Fedyanin, Larisa Zavalishina, et al.Immunotherapy|July 23, 2024
Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutationAnna Babayan, Evgeny Ledin, Alexandra Lebedeva, et al.Frontiers in Immunology|February 20, 2025
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive diseaseDaria Kravchuk, Alexandra Lebedeva, Olesya Kuznetsova, et al.Heliyon|May 6, 2024
Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experienceAlexandra Lebedeva, Olesya Kuznetsova, Maxim Ivanov, et al.JCO Precision Oncology|December 10, 2025
Neoadjuvant Immunotherapy With Prolgolimab in Patients With Locally Advanced Microsatellite Instability/Defective Mismatch Repair Colorectal CancerOlesya Kuznetsova, Albina Zagidullina, Natalia Drobot, et al.Pageof 2